CDEK
← All organizations

Eidos Therapeutics, Inc.

For profitWebsite ↗

Also known as: Eidos Therapeutics | Eidos Therapeutics, a BridgeBio company

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 11, 2017

Last known activity

Nov 30, 2025

Acquired by Bridge Biotherapeutics, Inc. on Oct 5, 2020

Timeline

2010s

  1. Jan 1, 2013

    Eidos Therapeutics, Inc.— Founded

2020s

  1. Oct 5, 2020

    Bridge Biotherapeutics, Inc.— Acquired By

Drugs by trial phase (2 distinct, 11 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

Details

Founded
San Francisco, CA, US Jan 1, 2013
Last known activity
Nov 30, 2025